Today’s Forbes Daily newsletter features a reprieve on weight loss drug prices, over 1 million jobs cut, holiday shopping expectations, Mark Zuckerberg’s drop and more.
ByDanielle Chemtob,
Forbes Staff
andForbes Daily,
Forbes Staff.
Americans will soon get a reprieve on the sky-high cost of some weight loss drugs thanks to a deal President Donald Trump announced Thursday.
The monthly out-of-pocket cost of popular injections and upcoming pills could range from $50 to $350, depending on the dosage and…
Here are five key things investors need to know to start the trading day.
The deal also means Medicare will start covering obesity drugs for some patients for the first time beginning next year.
US President Donald Trump announces agreements with drug makers Eli Lilly and Novo Nordisk.
The pharmaceutical giant and Novo Nordisk said they would lower the prices of their popular weight loss drugs to expand access.
Today’s Forbes Daily covers the latest private sector jobs figures, a promising shipbuilding startup, Pfizer’s big win and more.
